Inventor · disambiguated record
Kenneth L. Rock
Also filed as: ROCK KENNETH · ROCK KENNETH L
16 granted patents·9 pending applications·450 citations·filing 1991–2020
93Inventor score
Files withUNIV MASSACHUSETTS10DANA FARBER CANCER INST INC4ROCK KENNETH L3CORIXA CORP2UNIV PITTSBURGH1
Top patents by PatentIndex Score
25 records- 0196US8101586B2Methods and compositions for the treatment of sterile inflammationROCK KENNETH L·Filed 2010·Granted Jan 24, 2012·33 cites·10 claims
- 0295US5928647AInducing cytotoxic T lymphocyte responsesDANA FARBER CANCER INST INC·Filed 1994·Granted Jul 27, 1999·277 cites·20 claims
- 0388US6693176B1Antitumor antibodies, proteins, and uses thereofUNIV MASSACHUSETTS·Filed 2000·Granted Feb 17, 2004·24 cites·23 claims
- 0485US5951975AInduction of CTLs specific for natural antigens by cross priming immunizationUNIV PITTSBURGH·Filed 1996·Granted Sep 14, 1999·69 cites·22 claims
- 0579US7781569B2Antibodies to treat cancerUNIV MASSACHUSETTS·Filed 2006·Granted Aug 24, 2010·2 cites·26 claims
- 0678US7935338B2Antibodies to treat cancerUNIV MASSACHUSETTS·Filed 2002·Granted May 3, 2011·3 cites·50 claims
- 0775US7781212B2Antitumor antibodies, proteins, and uses thereofUNIV MASSACHUSETTS·Filed 2006·Granted Aug 24, 2010·1 cites·9 claims
- 0872US8444972B2Antitumor antibodies, proteins, and uses thereofROCK KENNETH L·Filed 2010·Granted May 21, 2013·1 cites·19 claims
- 0969US7807187B2Endogenous adjuvant molecules and uses thereofUNIV MASSACHUSETTS·Filed 2004·Granted Oct 5, 2010·3 cites·16 claims
- 1069US2010303817A1Antibodies to treat cancerUNIV MASSACHUSETTS·Filed 2009·Application pending·0 cites
- 1167US2006263374A1Antibodies to treat cancerCORIXA CORP·Filed 2006·Application pending·0 cites
- 1262US7902339B2Antitumor antibodies, proteins, and uses thereofUNIV MASSACHUSETTS·Filed 2006·Granted Mar 8, 2011·0 cites·12 claims
- 1362US2005026222A1Antitumor antibodies, proteins, and uses thereofFiled 2003·Application pending·0 cites
- 1460US2006275307A1Antibodies to treat cancerCORIXA CORP·Filed 2006·Application pending·0 cites
- 1558US8597664B2Endogenous adjuvant molecules and uses thereofROCK KENNETH L·Filed 2010·Granted Dec 3, 2013·0 cites·16 claims
- 1657US7736860B2Methods of identifying compounds for the treatment of sterile inflammationUNIV MASSACHUSETTS·Filed 2007·Granted Jun 15, 2010·0 cites·1 claims
- 1755US6328972B1Compositions and methods for inducing cytotoxic T lymphocyte responses by immunization with protein antigensFiled 1995·Granted Dec 11, 2001·15 cites·23 claims
- 1855US2004115204A1Antibodies to treat cancerFiled 2002·Application pending·0 cites
- 1951US2002054864A1Stimulation of cell-mediated immune responses by targeted particulate genetic immunizationFiled 2001·Application pending·0 cites
- 2051US2022299513A1Irf2 as a prognostic biomarker and target for augmenting immunotherapyUNIV MASSACHUSETTS·Filed 2020·Application pending·0 cites
- 2149US2010150938A1Methods and compositions for reducing inflammation and treating inflammatory disordersUNIV MASSACHUSETTS·Filed 2009·Application pending·0 cites
- 2248US5733550AMethod for enhancing the association of exogenous peptides with class I MHC molecules on the surface of antigen presenting cells with β-microglobulinDANA FARBER CANCER INST INC·Filed 1995·Granted Mar 31, 1998·11 cites·22 claims
- 2346US2003003086A1Modulation of MHC class I antigen presentationFiled 2002·Application pending·0 cites
- 2444US5348878AClass I MHC-restricted T-T hybridomas, and a CD8-transfected BW5147, fusion partner thereforDANA FARBER CANCER INST INC·Filed 1991·Granted Sep 20, 1994·7 cites·14 claims
- 2539US7176186B1Stimulation of cell-mediated immune responses by targeted particulate genetic immunizationDANA FARBER CANCER INST INC·Filed 1997·Granted Feb 13, 2007·4 cites·79 claims
Join the waitlist — get patent alerts
Get an alert when Kenneth L. Rock files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →